bioRxiv Science⌕ Search

bioRxiv · 10.64898/2025.12.18.694995

Phenotypes and Cellular Mechanics of Primary Human Aorta- and Pluripotent Stem Cell-derived Vascular Smooth Muscle Cells

Abstract

AimsMature, contractile vascular smooth muscle cells (vSMC) in the medial layer of muscular blood vessels can de-differentiate into synthetic vSMC, while human pluripotent stem cells (hPSC) differentiate into proliferating, fetal-like vSMC that can be induced to form contractile vSMC. Our aim was to define the mechanical properties of well-characterized in vitro-differentiated vSMC compared to vSMC derived from adult human aorta (AoSMC). Methods and ResultsWe generated paraxial mesoderm (PM)-derived synthetic and contractile vSMC from hPSC lines, and we obtained proliferating AoSMC. Immature, synthetic hPSC-vSMC are proliferative, sensitive to contact inhibition and exhibit phenotype switching. Contractile hPSC-vSMCs are non-proliferative, have elevated levels of contractile proteins, and can undergo phenotype switching in vitro into a proliferative form. Immunostaining of contractile proteins present in vSMCs (CNN1, MYH11, TAGLN, ACTA2) display similar cell-to-cell heterogeneities between AoSMC and hPSC-vSMCs. The fluorescent signals are relatively uniform at sub-confluency, but highly variable at confluency. Human PSC-vSMC maintain doubling rates more readily and are more easily enriched using lactate medium than AoSMC. The single cell mechanics of AoSMC and hPSC-vSMC, assessed using micropost array detectors (mPADs), are highly comparable and have an average force production per micropost in the nN range. When cultivated to form humanized smooth muscle cell microtissues (SMTs), developed forces normalized to cell numbers are similar to that seen using microarray post detectors. Maximum developed forces in these tissues could be measured in response to endothelin-1. ConclusionsThese results demonstrate that synthetic hPSC-vSMCs and proliferating AoSMCs are highly comparable, and mechanically similar, but results with hPSC-vSMC are more reproducible. This study establishes the hPSC-vSMCs as a reproducible system to study how changes in cellular mechanics may contribute to development and disease. Translational PerspectiveThe mechanical properties and responses of lineage-specific human vSMC undergoing phenotype switching during perinatal development and vascular pathologies remain poorly understood. We have employed paraxial-mesoderm derived hPSC-vSMC, which recapitulate phenotypic properties of AoSMC, to define the mechanical properties of synthetic and contractile vSMCs. We quantitatively measured the forces of individual vSMC and of multicellular vSMC constructs. By defining the mechanical changes of normal vSMCs to phenotype switching, this validated, adaptable system advance studies of vSMC mechanics that may contribute to vascular pathologies in patients.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Huang, C.-Y., Wu, S. C. M., Kissling, M., Arking, A., Chen, Y.-W., Hall, F. D., Sivarajan, S., Yezzi, H., Reich, D. H., Boheler, K. R.. 2025-12-22. Phenotypes and Cellular Mechanics of Primary Human Aorta- and Pluripotent Stem Cell-derived Vascular Smooth Muscle Cells. https://doi.org/10.64898/2025.12.18.694995

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The nuclear membrane protein Samp1 links peripheral genome organization to the myogenic transcriptional program

Samp1 is an inner nuclear membrane protein required for myogenic differentiation and involved in chromatin organization at the nuclear periphery. Here, we investigated whether these functions are connected by studying the effects of Samp1 depletion during C2C12 myogenic differentiation using immunofluorescence microscopy, RNA sequencing, FRIC, and chromosome-positioning analysis. Samp1-depleted cells showed strongly reduced MyHC expression and virtually abrogated multinucleated fiber formation. Although cell-cycle withdrawal was not prevented, the transcriptional program driving differentiation was drastically perturbed, with reduced muscle-associated transcripts and incomplete repression of genes normally downregulated during myogenesis. Samp1 depletion also disrupted peripheral chromatin organization and prevented the accumulation of peripheral heterochromatin typically seen during differentiation. In addition, radial chromosome distribution was disrupted, evidenced by the failure of chromosome 8 to reposition to the nuclear periphery during differentiation. Together, these findings link the requirement for Samp1 in myogenic differentiation to its role in genome organization at the nuclear periphery.

cell biology↗

Unraveling the metabolic landscape of alkaptonuria through a human-relevant in vitro liver disease model

Alkaptonuria (AKU) is a rare inherited metabolic disorder of tyrosine catabolism caused by a deficient homogentisate 1,2-dioxygenase (HGD) enzyme. This results in the accumulation of homogentisic acid (HGA), driving a progressive multisystem pathology characterized by debilitating early-onset osteoarthritis due to connective tissue degeneration. While previous in vitro studies have primarily relied on exogenous HGA exposure in osteoarticular cell models, the direct metabolic consequences of endogenous HGD deficiency within its native hepatic context remain poorly understood. Here, we established the first human-relevant HGD knockout hepatic in vitro model using a universal in-house-developed homology-directed repair approach. Integrative multi-omic analysis revealed that HGD deficiency induces widespread metabolic rewiring extending beyond disrupted tyrosine catabolism. HGD-deficient hepatocytes exhibited elevated oxidative stress accompanied by impaired mitochondrial respiration and a pseudohypoxic metabolic adaptation toward increased glycolytic dependency. Despite this glycolytic shift, the cells displayed reduced anabolic and translational activity alongside attenuated proliferation, consistent with a chronic stress-adaptive survival state rather than a proliferative metabolic phenotype. This study provides systems-level insights into the pathophysiology of AKU and establishes a versatile platform for mechanistic and therapeutic investigation.

cell biology↗

The circadian clock regulates KCNH2 (hERG) promoter activity through daily temperature rhythms.

Background: KCNH2 encodes Kv11.1 channel proteins that conduct the rapidly activating delayed-rectifier K+ current (IKr), which is critical for cardiac repolarization. KCNH2 encodes two functional isoforms, Kv11.1a and Kv11.1b, via alternative transcription start sites. Kv11.1a is the principal determinant of cardiac IKr and ventricular repolarization. The circadian clock, a transcriptional-translational feedback loop that cycles with a period of ~24 hours and drives the circadian expression of many genes, including Kcnh2 in the mouse heart. Because daily body temperature rhythms provide a systemic signal that synchronizes cardiac circadian clocks, we tested whether physiological temperature cycles drive the circadian promoter activity of the cloned human KCNH2 (hKCNH2) promoter. Hypothesis: hKCNH2 is a direct transcriptional target of the circadian clock, with temperature driving its promoter activity through BMAL1:CLOCK acting at a conserved tandem E-box. Methods: We cloned the conserved proximal promoter of KCNH2 (-1631 bp upstream of Kv11.1a exon 1) to generate hKCNH2 promoter luciferase reporter constructs. Constructs were transfected into C2C12 myotubes and synchronized by serum shock (static 37{degrees}C) or temperature cycling (36.5-38.5{degrees}C). Bioluminescence was recorded and assessed for period, phase, and amplitude. BMAL1:CLOCK dependence was tested via dominant-negative CLOCK{Delta}19 co-expression. Results: Temperature cycling did not exhibit the rapid damping characteristic of serum-shock-synchronized oscillations, consistent with continuous entrainment by an external zeitgeber rather than a free-running oscillator. Deletion analysis identified a conserved tandem E-box required for oscillation under both serum shock and temperature cycling, and for BMAL1:CLOCK-dependent transactivation (1.75 {+/-} 0.21 vs. 0.86 {+/-} 0.06 RLU, p = 0.0038). CLOCK{Delta}19 reduced hKCNH2 promoter amplitude under temperature cycling without altering period. Conclusion: The circadian clock regulates KCNH2 promoter activity through daily temperature rhythms.

cell biology↗